STABLE AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING TEZOSENTAN

Difficulties in preparing a stable pharmaceutical composition containing 5- Isopropyl-pyridine-2- sulfonic acid 6-(2-hydroxy-ethoxy)-5(2-methoxy- phenoxy)2-(2-1H-tetrazol-5-y l- pyridin-4yl)- pyrimidin-4-ylamide in form of the water soluble disodium salt, a buffer and preferably a metal complex form...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: LOELIGER, PETER
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LOELIGER, PETER
description Difficulties in preparing a stable pharmaceutical composition containing 5- Isopropyl-pyridine-2- sulfonic acid 6-(2-hydroxy-ethoxy)-5(2-methoxy- phenoxy)2-(2-1H-tetrazol-5-y l- pyridin-4yl)- pyrimidin-4-ylamide in form of the water soluble disodium salt, a buffer and preferably a metal complex forming agent, have been encountered. It was unexpectedly found that these difficulties can be overcome by adjusting the pH of the solution with an aci d to over and above 8,2, preferably to 9,0, but not higher than 10.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2308660C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2308660C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2308660C3</originalsourceid><addsrcrecordid>eNrjZLAPDnF08nFVcAwMdfUPDVYI8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wOzgzyDPf3cFUJco_yDXf1CHP14GFjTEnOKU3mhNDeDvJtriLOHbmpBfnxqcUFicmpeakm8s6ORsYGFmZmBszFhFQAf_SoZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABLE AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING TEZOSENTAN</title><source>esp@cenet</source><creator>LOELIGER, PETER</creator><creatorcontrib>LOELIGER, PETER</creatorcontrib><description>Difficulties in preparing a stable pharmaceutical composition containing 5- Isopropyl-pyridine-2- sulfonic acid 6-(2-hydroxy-ethoxy)-5(2-methoxy- phenoxy)2-(2-1H-tetrazol-5-y l- pyridin-4yl)- pyrimidin-4-ylamide in form of the water soluble disodium salt, a buffer and preferably a metal complex forming agent, have been encountered. It was unexpectedly found that these difficulties can be overcome by adjusting the pH of the solution with an aci d to over and above 8,2, preferably to 9,0, but not higher than 10.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080812&amp;DB=EPODOC&amp;CC=CA&amp;NR=2308660C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20080812&amp;DB=EPODOC&amp;CC=CA&amp;NR=2308660C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LOELIGER, PETER</creatorcontrib><title>STABLE AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING TEZOSENTAN</title><description>Difficulties in preparing a stable pharmaceutical composition containing 5- Isopropyl-pyridine-2- sulfonic acid 6-(2-hydroxy-ethoxy)-5(2-methoxy- phenoxy)2-(2-1H-tetrazol-5-y l- pyridin-4yl)- pyrimidin-4-ylamide in form of the water soluble disodium salt, a buffer and preferably a metal complex forming agent, have been encountered. It was unexpectedly found that these difficulties can be overcome by adjusting the pH of the solution with an aci d to over and above 8,2, preferably to 9,0, but not higher than 10.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAPDnF08nFVcAwMdfUPDVYI8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wOzgzyDPf3cFUJco_yDXf1CHP14GFjTEnOKU3mhNDeDvJtriLOHbmpBfnxqcUFicmpeakm8s6ORsYGFmZmBszFhFQAf_SoZ</recordid><startdate>20080812</startdate><enddate>20080812</enddate><creator>LOELIGER, PETER</creator><scope>EVB</scope></search><sort><creationdate>20080812</creationdate><title>STABLE AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING TEZOSENTAN</title><author>LOELIGER, PETER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2308660C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>LOELIGER, PETER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LOELIGER, PETER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABLE AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING TEZOSENTAN</title><date>2008-08-12</date><risdate>2008</risdate><abstract>Difficulties in preparing a stable pharmaceutical composition containing 5- Isopropyl-pyridine-2- sulfonic acid 6-(2-hydroxy-ethoxy)-5(2-methoxy- phenoxy)2-(2-1H-tetrazol-5-y l- pyridin-4yl)- pyrimidin-4-ylamide in form of the water soluble disodium salt, a buffer and preferably a metal complex forming agent, have been encountered. It was unexpectedly found that these difficulties can be overcome by adjusting the pH of the solution with an aci d to over and above 8,2, preferably to 9,0, but not higher than 10.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2308660C
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title STABLE AQUEOUS PHARMACEUTICAL COMPOSITION COMPRISING TEZOSENTAN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A16%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LOELIGER,%20PETER&rft.date=2008-08-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2308660C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true